-
An Exploratory Study Investigating the Potential Application of Coping Strategies for Pain Used by Athletes and Their Potential Application to Patients Dealing with Chronic Pain
Joseph D. Harrington, BS; Erika L. Manning, PhD, MD, MPH; and Robert J. Diecidue, DMD, MD, MBA, MSPH
Abstract
- High-level athletes often have elevated tolerance for experimental pain methods.1
- Research has not focused on the specific mechanisms behind this.
- The current study was designed to assess the potential role of coping strategies in this elevated pain tolerance - Phase 2 will examine if they can be taught to chronic orofacial pain patients.
- During Phase 1, the Coping Strategies Questionnaire2 was modified for athletes and was distributed to 50 athletes to assess how athletes dealt with pain.
- In comparison to TMD patients, more of the athletes reported that they chose to ignore or reinterpret the pain, or increase behavioral activities. Athletes do not appear to catastrophize as much as TMD patients.3
Phase 1: Identify Athletic Coping Methods
Phase 2: Teach to Patients
-
Reconstruction of Marginal Mandibular Defects Utilizing Bone Marrow Aspirate Concentrate (BMAC) from the Anterior Iliac Crest: A Less Morbid Osteogenic Option
Shachika Khanna, BDS, DMD; Rafael Gavilanes, DMD; Robert Diecidue, DMD, MD, MBA, MSPH; Daniel Taub, DDS, MD; and Alyssa Flashburg, DMD
The aim of this case series, is to describe our surgical technique for reconstructing benign mandibular neoplasms using BMAC – a less invasive approach than traditional iliac crest bone graft harvest.
BMAC was used in combination with mineralized freeze-dried allograft, platelet rich plasma (PRP) & bone morphogenic protein (rhBMP-2) to reconstruct the hard tissue lost secondary to the ablative tumor resection.
- 10 patients included in the retrospective case series were treated between 2014 and 2017 by 3 surgeons.
- Mean age - 44 years (range - 19 to 77 years). BMAC was obtained from the anterior iliac crest (AIC).
- When appropriate, a custom milled mandibular reconstruction plate was placed.
- Maxillofacial pathology included benign neoplasms such as Ameloblastoma, Cavernous Hemangioma, Central Giant Cell Granuloma (CGCG), Dentigerous Cyst & Keratocystic Odontogenic Tumor (KOT).
-
Treatment of Obstructive Sleep Apnea with Maxillo-mandibular Advancement Surgery: Evaluation and Predictors of Success
Daniel Taub, DMD, MD; Michael Courtney, DMD, MD; and Karl Doghramji, MD
Obstructive sleep apnea (OSA) is a well-recognized disease entity affecting approximately 2% to 4% of the population. Maxillomandibular advancement (MMA) surgery is a highly successful surgical alternative to poorly tolerated CPAP therapy and achieves a success rate of 89% in the current literature. Our present study evaluates the effectiveness of MMA surgery in the treatment of patients with moderate to severe OSA based on Shers criteria of 50% reduction in AHI and AHI < 20. Radiographic and clinical treatment variables were evaluated in determining predictors of success for MMA in individuals with OSA.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.